Forms and Documents
- HFE-HH can be confirmed with molecular genetic testing by identifying biallelic pathogenic variants in the HFE gene. The majority (~90%) of HH patients have biallelic pathogenic variants in the HFE gene.
*The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.